Contemporary Clinical Trials, published by Elsevier Science Inc, stands at the forefront of clinical research, providing a dedicated platform for the dissemination of innovative studies and methodologies in medicine and pharmacology. With an impressive impact factor reflecting its consistent contributions to the field, this journal is categorized in the Q1 quartile for both Medicine (miscellaneous) and Pharmacology (medical) as of 2023. The journal's scope encompasses a broad range of topics pertinent to clinical trial design, execution, and analysis, aiming to enhance the effectiveness and safety of therapeutic interventions. Operating under an Open Access model, it ensures that the latest research is accessible to a global audience, fostering collaboration and discussion among researchers, professionals, and students alike. In publishing high-quality articles since its inception in 2005, Contemporary Clinical Trials continues to shape the future of clinical research with its commitment to excellence and innovation.

BIOSTATISTICS is a premier academic journal dedicated to the intersection of statistical methodologies and their applications in the field of biomedicine, published by Oxford University Press. With its ISSN 1465-4644 and E-ISSN 1468-4357, the journal has established itself as a crucial resource for researchers and professionals in the broad disciplines of statistics and probability, particularly within medical contexts. The journal proudly holds a Q1 ranking in multiple categories as of 2023, including Medicine (miscellaneous), Statistics and Probability, as well as Statistics, Probability, and Uncertainty, placing it at the forefront of statistical research. It has also achieved notable Scopus rankings, underscoring its influence and reach—ranking 27th in Mathematics (Statistics and Probability) and 94th in Medicine (General Medicine). Although it does not currently offer open access options, BIOSTATISTICS remains committed to advancing scholarly conversation and innovation in statistical science, making it an essential outlet for both established and emerging researchers. With contributions spanning from 2003 to 2024, this journal is actively seeking to foster an understanding of complex statistical approaches in biomedicine, enabling professionals in the field to apply robust statistical techniques to real-world problems.

CLINICAL PHARMACOLOGY & THERAPEUTICS, published by WILEY, stands at the forefront of pharmacological research, serving as a pivotal resource for researchers, healthcare professionals, and students in the medical field. With its prestigious Q1 rating in both Pharmacology and Pharmacology (medical) categories, and ranking in the top 4% of journals in the field, it provides cutting-edge insights into drug therapy, pharmacokinetics, and innovative treatment strategies. The journal features a wide range of articles, from original research to comprehensive reviews, all aimed at advancing knowledge and clinical practice in pharmacology. With a publication history dating back to 1960 and continuing through 2024, its commitment to excellence is evident in its robust impact factor and high visibility in the academic community. For professionals striving to stay at the forefront of pharmacological advancements, CLINICAL PHARMACOLOGY & THERAPEUTICS remains an essential platform for disseminating and accessing vital research findings.

AUSRALIAN & NEW ZEALAND JOURNAL OF STATISTICS, published by Wiley, stands as a significant platform for the dissemination of statistical knowledge and applications, specifically within the realms of statistics and probability. With an impact factor reflective of its quality and standing, the journal operates in a Q3 category for both Statistics and Probability, as well as Statistics, Probability, and Uncertainty, positioning it among the important scholarly resources in its field. As a valuable resource for researchers, professionals, and students, the journal encourages the submission of innovative research articles that push the boundaries of statistical science. Offering both print and open access options, it ensures broad accessibility, promoting a culture of collaboration and knowledge sharing across the global statistical community. Covering research from 1998 to 2024, it remains dedicated to advancing understanding in statistical methodologies and their applications, cementing its role in fostering academic discourse and practical advancements in the field.

Statistics in Medicine, published by Wiley, is a prestigious journal dedicated to the advancement of statistical methods and their application in biomedical research. Established in 1982, this journal has become a cornerstone in the fields of Epidemiology and Statistics and Probability, demonstrating its importance by consistently achieving a Q1 ranking in the 2023 category quartiles. With an impressive ISSN of 0277-6715 and an E-ISSN of 1097-0258, it serves as a vital platform for disseminating high-quality research that enhances evidence-based medicine. Although the journal does not currently offer open access, it remains highly regarded, holding a Scopus rank of #66 in Mathematics and #80 in Medicine, indicating its significant impact on the academic community. By publishing cutting-edge research, Statistics in Medicine aims to bridge the gap between statistical theory and practical application in health domains, fostering a rigorous dialogue among researchers, clinicians, and statisticians alike.

Metron-International Journal of Statistics is a prestigious peer-reviewed journal published by SPRINGER-VERLAG ITALIA SRL, dedicated to advancing the field of statistics and probability. With an ISSN of 0026-1424 and an E-ISSN of 2281-695X, this journal has been a vital platform for scholarly research since its inception in 1973, showcasing works that redefine methodologies and applications within the field. Positioning itself in Q3 of the 2023 statistics category quartiles, Metron aims to foster dialogue and innovation among researchers and practitioners. Although currently not an open-access publication, it provides invaluable insights that contribute significantly to the statistical community's body of knowledge. Serving a diverse global audience, the journal encourages submissions that address both theoretical frameworks and practical applications in statistics, promising to enhance the rigor and relevance of statistical practice. Based in Milan, Italy, Metron continues to uphold its commitment to excellence in statistical research through thorough peer review and a focus on impactful findings.

BMC Medical Research Methodology is a prestigious open-access journal published by BMC, dedicated to advancing the field of medical research methodologies. Launched in 2001, the journal has established itself as a vital resource for researchers, reflecting its high-quality contributions with a strong Q1 ranking in both Epidemiology and Health Informatics as of 2023. As a scholarly platform, it offers broad access globally, ensuring that the latest developments in research methodology are readily available to professionals, scholars, and students alike. With its commitment to enhancing the rigor and transparency of medical research, BMC Medical Research Methodology plays a critical role in shaping the future of evidence-based practices, making it an essential read for anyone involved in medical research. The journal is based in the United Kingdom at CAMPUS, 4 Crinan St, London N1 9XW, England, and provides comprehensive access options to facilitate the dissemination of knowledge and foster collaboration across the global research community.

STATISTICAL METHODS IN MEDICAL RESEARCH is a leading academic journal dedicated to advancing the field of statistical methodologies as they apply to medical research. Published by SAGE Publications Ltd, this prestigious journal focuses on innovative statistical techniques that are pivotal for health-related data analysis and interpretation. With its Q1 ranking in Epidemiology, Health Information Management, and Statistics and Probability as of 2023, it stands out as a vital resource for researchers and practitioners alike. The journal, which has been in circulation since 1992, is widely recognized for its robust contributions to evidence-based medicine and public health, ensuring that practitioners have access to cutting-edge research. Although it currently does not offer Open Access options, the high-impact nature indicated by its rankings and percentile positions solidifies its importance as a go-to source for statistical theories and applications in health research. Researchers, healthcare professionals, and students are encouraged to explore the rich content of this journal to stay abreast of the latest advancements and methodologies.

The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.

Statistics and Its Interface, issn 1938-7989, published by INT PRESS BOSTON, INC, is a vital academic journal dedicated to bridging the critical intersection of statistics, applied mathematics, and interdisciplinary research. With its inaugural publication in 2011, this journal has continually aimed to provide a platform for innovative statistical methods and their application across various fields, offering valuable insights for researchers and practitioners alike. While the journal currently operates without an open access model, it maintains an essential position within the scholarly community, evidenced by its 2023 rankings in the third quartile for Applied Mathematics and the fourth quartile for Statistics and Probability. Furthermore, it holds a respectable position in Scopus rankings, reflecting its commitment to quality over quantity. By publishing cutting-edge research, Statistics and Its Interface serves as a critical resource for advancing statistical knowledge and cultivating a deeper understanding of its applications in real-world contexts.